State Street’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.2K | Hold |
87,002
| – | – | ﹤0.01% | 3989 |
|
|
2025
Q1 | $118K | Hold |
87,002
| – | – | ﹤0.01% | 3937 |
|
|
2024
Q4 | $120K | Buy |
87,002
+26,700
| +44% | +$36.8K | ﹤0.01% | 3957 |
|
|
2024
Q3 | $64.5K | Hold |
60,302
| – | – | ﹤0.01% | 4055 |
|
|
2024
Q2 | $130K | Hold |
60,302
| – | – | ﹤0.01% | 3932 |
|
|
2024
Q1 | $196K | Buy |
60,302
+22,000
| +57% | +$71.5K | ﹤0.01% | 3877 |
|
|
2023
Q4 | $785K | Buy |
38,302
+22,900
| +149% | +$469K | ﹤0.01% | 3529 |
|
|
2023
Q3 | $248K | Sell |
15,402
-2,700
| -15% | -$43.4K | ﹤0.01% | 3871 |
|
|
2023
Q2 | $154K | Sell |
18,102
-78,782
| -81% | -$670K | ﹤0.01% | 4086 |
|
|
2023
Q1 | $956K | Buy |
96,884
+5,862
| +6% | +$57.9K | ﹤0.01% | 3546 |
|
|
2022
Q4 | $867K | Buy |
91,022
+37,341
| +70% | +$356K | ﹤0.01% | 3591 |
|
|
2022
Q3 | $933K | Buy |
53,681
+8,459
| +19% | +$147K | ﹤0.01% | 3609 |
|
|
2022
Q2 | $350K | Buy |
+45,222
| New | +$350K | ﹤0.01% | 3977 |
|